Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Novartis Vaccines And Diagnostics Inc
Novartis Vaccines And Diagnostics Inc Formerly Known As Chiron Corporation
Novartis Vaccines And Diagnostics Inc_20100128
Novartis Vaccines And Diagnostics Inc_20100121
  

Novartis Vaccines And Diagnostics Inc patents

Recent patent applications related to Novartis Vaccines And Diagnostics Inc. Novartis Vaccines And Diagnostics Inc is listed as an Agent/Assignee. Note: Novartis Vaccines And Diagnostics Inc may have other listings under different names/spellings. We're not affiliated with Novartis Vaccines And Diagnostics Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | Novartis Vaccines And Diagnostics Inc-related inventors




Date Novartis Vaccines And Diagnostics Inc patents (updated weekly) - BOOKMARK this page
06/01/17M-csf specific monoclonal antibody and uses thereof
03/23/17Antagonist anti-cd40 monoclonal antibodies and methods for their use
05/05/16Angiogenically effective unit dose of fgf and administering
01/21/16M-csf specific monoclonal antibody and uses therof
12/24/15Nucleic acids and proteins from streptococcus groups a and b
10/22/15Influenza vaccination
03/12/15Microparticles with adsorbed polynucleotide-containing species
01/29/15Cell transfecting formulations of small interfering rna, related compositions and methods of making and use
01/22/15Alphavirus vectors for respiratory pathogen vaccines
11/27/14Angiogenically effective unit dose of fgf-2 and use
10/30/14Method for determining the concentration of virus particles/virus antigens
08/28/14M-csf specific monoclonal antibody and uses thereof
07/24/14Antagonist anti-cd40 monoclonal antibodies and methods for their use
06/12/14Adjuvant compositions
05/22/14Angiogenically effective unit dose of fgf and administering
04/10/14Method for producing yeast expressed hpv types 6 and 16 capsid proteins
01/02/14Group b streptococcus vaccine
11/28/13Compositions and methods for stimulating an immune response against infectious agents
08/01/13Microemulsions with adsorbed macromolecules and microparticles
08/01/13Microemulsions with adsorbed macromolecules and microparticles
08/01/13Genes differentially expressed in breast cancer
05/23/13Nucleic acids and proteins from streptococcus groups a and b
04/18/13Norovirus and sapovirus antigens
04/04/13Methods and reagents for diagnosing hantavirus infection
01/10/13Antagonist anti-cd40 monoclonal antibodies and methods for their use
11/15/12Angiogenically effective unit dose of fgf-2 and use
10/25/12Expression of hiv polypeptides and production of virus-like particles
09/27/12Use of tryptanthrin compounds for immune potentiation
07/19/12Hiv tat-cd4 hybrid molecules and methods of use thereof
07/12/12Fusion proteins comprising cd4 minimal modules and methods of use thereof
07/05/12Mucosal boosting following parenteral priming
06/28/12Angiogenically effective unit dose of fgf and administering
05/17/12Modified small interfering rna molecules and methods of use
05/10/12Nucleic acid mucosal immunization
05/03/12Protective anti-glucan antibodies with preference for beta-1,3-glucans
01/19/12Identification of oligonucleotides for the capture, detection and quantitation of west nile virus
09/15/11Mucosal and systemic immunization with alphavirus replicon particles
07/28/11Two stage enrichment of cell-free fetal dna in maternal plasma
07/14/11Antibacterial agents
07/14/11Method for isolating cell free apoptotic or fetal nucleic acids
06/30/11Immunogenic compositions for chlamydia trachomatis
05/12/11Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
03/17/11Expression of hiv polypeptides and production of virus-like particles
03/03/11Hiv polynucleotides and polypeptides derived from botswana mj4
03/03/11Methods and reagents for diagnosing hantavirus infection
02/24/11Hiv vaccine for mucosal delivery
02/10/11Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
01/27/11Endogenous retroviruses up-regulated in prostate cancer
01/27/11Hiv envelope-cd4 complexes and hybrids
01/06/11Alphavirus vectors for respiratory pathogen vaccines
11/25/10Protective anti-glucan antibodies with preference for beta-1,3-glucans
10/21/10Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/07/10Substituted benzimidazoles and methods of preparation
09/30/10Pyrimidine derivatives used as pi-3-kinase inhibitors
09/23/10Compositions for inducing immune responses
09/16/10Substituted benzimidazoles and methods of their use
08/05/10Microparticle-based transfection and activation of dendritic cells
08/05/10Substituted benz-azoles and methods of their use as inhibitors of raf kinase
07/22/10Quinolinone derivatives
07/08/10Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/08/10Treatment of metastasized tumors
04/15/10Modified hiv env polypeptides
04/08/10Vectors for expression of hml-2 polypeptides
03/04/10Method for the purification of alphavirus replicon particles
02/18/10Polycistronic hiv vector constructs
Patent Packs
01/28/10Use of microparticles with adsorbed antigen to stimulate immune responses
01/21/10Polypeptides from neisseria meningitidis
12/24/092,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of raf kinase
12/10/09Chimeric alphavirus replicon particles
10/08/09Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
08/27/09Serum resistance factors of gram positive bacteria
07/30/09Adjuvant formulation comprising a submicron oil droplet emulsion
07/16/09Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
07/02/09Angiogenically effective unit dose of fgf and administering
07/02/09Mitotic kinesin inhibitors
05/21/09Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
04/23/09Alphavirus vectors for respiratory pathogen vaccines
04/09/09Truncated keratinocyte growth factor (kgf) having increased biological activity
04/02/09Novel hcv non-structural polypeptide
03/26/09Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
Patent Packs
03/26/09Hiv vaccine for mucosal delivery
03/19/09Gsk-3 inhibitors
01/28/10Use of microparticles with adsorbed antigen to stimulate immune responses
01/21/10Polypeptides from neisseria meningitidis
11/15/12Substituted benzazoles and methods of their use as inhibitors of raf kinase







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Novartis Vaccines And Diagnostics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Novartis Vaccines And Diagnostics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';